A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2013
11/28/2013	WO2013174403A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
11/28/2013	WO2013174264A1 Anti-blys antibody
11/28/2013	WO2013174003A1 Compositions and methods related to prevention and treatment of rabies infection
11/28/2013	WO2013173910A1 A novel toxin in type a clostridium perfringens
11/28/2013	WO2013148686A3 Stable igg4 binding agent formulations
11/28/2013	WO2013144811A3 Methods and compositions for treating inflammation
11/28/2013	WO2013085889A8 Identification and cloning of transmitted hepatitic c virus (hcv) genomes by single genome amplification
11/28/2013	WO2002101078A8 Cellulases, nucleic acids encoding them and methods for making and using them
11/28/2013	US20130318648 Diagnosis and therapeutic epitope, and transgenic plant
11/28/2013	US20130317457 Aqueous Pharmaceutical Composition Containing A Biologic Therapeutic Agent And Guanidine Or A Guanidine Derivative And An Injection Including The Composition
11/28/2013	US20130316434 Animal Protein Free Media for Cultivation of Cells
11/28/2013	US20130316326 Animal model for the evaluation of the efficacy of an hiv vaccine
11/28/2013	US20130315964 Pharmaceutical composition and method of inhibiting of production or amplifying of elimination of p24 protein
11/28/2013	US20130315961 Generation of novel bone forming cells (monoosteophils) from ll-37 treated monocytes
11/28/2013	US20130315960 Conjugated beta-1,3-linked glucans
11/28/2013	US20130315959 Compounds
11/28/2013	US20130315958 Pneumococcal serotypes
11/28/2013	US20130315957 Method of treating vertigo
11/28/2013	US20130315956 Newcastle disease virus and the use thereof as a vaccine
11/28/2013	US20130315955 Stability and potency of hemagglutinin
11/28/2013	US20130315954 Method for improving the production of influenza viruses and vaccine seeds
11/28/2013	US20130315952 Administration of interferon for prophylaxis against or treatment of pathogenic infection
11/28/2013	US20130315951 Compositions and methods for stimulating an immune response against infectious agents
11/28/2013	US20130315950 Methods and compositions using listeria for adjuvant treatment of cancer
11/28/2013	US20130315949 Molecular Antigen Array
11/28/2013	US20130315948 Controlled release formulation based on hematin anhydride crystals for the induction of an innate immune reaction
11/28/2013	US20130315947 Vaccination of Animals to Elicit a Protective Immune Response Against Tick Infestations and Tick-Borne Pathogen Transmission
11/28/2013	US20130315946 Vaccine composition against streptococcus pyogenes infection
11/28/2013	US20130315945 Yeast-based vaccines as immunotherapy
11/28/2013	US20130315941 Yeast-muc1 immunotherapeutic compositions and uses thereof
11/28/2013	US20130315935 Oligomeric receptor ligand pair member complexes
11/28/2013	US20130315932 Methods and pharmaceutical compositions for the treatment of heart failure
11/28/2013	US20130315929 Vaccine antigens that direct immunity to conserved epitopes
11/28/2013	US20130315927 Pcsk9 antagonists
11/28/2013	US20130315926 Methods and materials for modulating resistance to apoptosis
11/28/2013	US20130315925 Method for treating and preventing type 2 diabetes
11/28/2013	US20130315924 Subdermal Tissue Remodeling Using Myostatin, Methods and Related Systems
11/28/2013	US20130315922 Method for inducing lymphoid tissue and modulating intestinal homeostasis
11/28/2013	US20130315912 Antibodies that Bind to Adrenomedullin and to Adrenomedullin Receptors and the Uses Thereof as Drugs
11/28/2013	US20130315904 Combinations of modalities for the treatment of diabetes
11/28/2013	US20130315901 Novel uses
11/28/2013	US20130315899 Methods and compositions for diagnostic use in cancer patients
11/28/2013	US20130315897 Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor
11/28/2013	US20130315895 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
11/28/2013	US20130315893 Humanized anti-il-20 antibody and uses thereof
11/28/2013	US20130315892 Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor
11/28/2013	US20130315857 Kexin-Derived Vaccines to Prevent or Treat Fungal Infections
11/28/2013	US20130315823 Sparc binding peptides and uses thereof
11/28/2013	US20130315820 Use of an antibody directed against a membrane protein
11/28/2013	US20130315819 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
11/28/2013	DE10144906B4 Verfahren zur großtechnischen Herstellung von Impfstoffen A process for the large scale production of vaccines
11/27/2013	EP2666784A2 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
11/27/2013	EP2666480A2 Uses and compositions for treatment of Crohn's desease
11/27/2013	EP2666479A2 Uses and compositions for treatment of juvenile rheumatoid arthritis
11/27/2013	EP2666478A2 Uses and compositions for treatment of psoriasis
11/27/2013	EP2666477A1 Lentiviral vectors containing an MHC class I promoter
11/27/2013	EP2665751A1 Binding proteins to inhibitors of coagulation factors
11/27/2013	EP2665521A2 Compositions and methods for treating cancer
11/27/2013	EP2665490A1 Vaccines and compositions against streptococcus pneumoniae
11/27/2013	CN103415534A Antigen presenting cell targeted cancer vaccines
11/27/2013	CN103415301A Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
11/27/2013	CN103409455A Egg yolk antibody anti-human enterotoxigenic escherichia coli adhesion protein and application thereof
11/27/2013	CN103409454A Preparation method of JEV (Japanese encephalitis virus) dominant antigen epitope E1-402aa recombinant plasmid and vaccine
11/27/2013	CN103409453A Preparation method of recombinant panda IL-6 immunological adjuvant
11/27/2013	CN103409377A Preparation and use of canine parvovirus virus-like particles
11/27/2013	CN103409376A JEV (Japanese Encephalitis Virus) / WNV (West Nile Virus) chimeric virus and application thereof
11/27/2013	CN103409374A Trigeminy inactivated vaccine for porcine circovirus disease, porcine streptococcus suis disease and porcine haemophilus parasuis disease, preparation method of the vaccine and applications of the vaccine
11/27/2013	CN103409364A Culture medium suitable for preparing porcine circovirus type II vaccine through PK15 cell and using method thereof
11/27/2013	CN103408666A Humanized anti-AEG-1 single chain antibody and application thereof
11/27/2013	CN103408660A Monoclonal antibody of antiplague bacillus F1 antigen and application of monoclonal antibody
11/27/2013	CN103408656A Morphine/heroin vaccine formed by covalently binding hapten and carrier, and application thereof
11/27/2013	CN103408642A Vibrio harveyi outer membrane protein and application thereof
11/27/2013	CN103405768A Methods for the treatment of IL-1[beta] related diseases
11/27/2013	CN103405767A Difunctional vaccine combining virus-like particle and monoclonal antibody for infectious bursal disease
11/27/2013	CN103405766A Bevacizumab eye drop and preparation method thereof
11/27/2013	CN103405765A Yolk powder-aplysia evasion hormone compound preparation and preparation method thereof
11/27/2013	CN103405764A Vaccine compositions comprising a saponin adjuvant
11/27/2013	CN103405763A Application of heat shock protein 70 as immunoadjuvant
11/27/2013	CN103405762A Polyinosinic acid-polycytidylic acid dominated adjuvant
11/27/2013	CN103405761A Liquid vaccines for multiple meningococcal serogroups
11/27/2013	CN103405760A Application of edwardsiella tarda pilin FimA
11/27/2013	CN103405759A Method for preparing tumor-specific DC vaccine by applying CD34+ cells of umbilical cord blood
11/27/2013	CN103405758A Method for preparing tumor-specific DC vaccine by applying mononuclear cells in umbilical cord blood
11/27/2013	CN102961337B Preparation method of target compound nano particle
11/27/2013	CN102731617B Hantavirus glucoprotein specific T cell epitope peptide and application thereof
11/27/2013	CN102675471B Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof
11/27/2013	CN102633898B Optimization method of Hib polysaccharide and protein binding process
11/27/2013	CN102399266B Immunogenic peptide of humvoltage-gated potassium channel 1.5 (hKv1.5) and purpose thereof
11/27/2013	CN102307900B Antibody modulating differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof
11/27/2013	CN102219835B Long peptide based on HCA587 antigen and its application in preparing antitumor drugs
11/27/2013	CN101998990B Improvements in preparation of influenza virus vaccine antigens
11/27/2013	CN101612399B PDGFR-alpha antagonists for treatment of metastatic bone cancer
11/27/2013	CN101610785B 多价肺炎球菌多糖-蛋白质缀合物组合物 Multivalent pneumococcal polysaccharide - protein conjugate composition
11/27/2013	CN101500607B Use of TNFalpha inhibitor for treatment of erosive polyarthritis
11/27/2013	CN101443360B Binding member for GM-CSF receptor
11/26/2013	US8592566 Immunostimulatory oligonucleotides and use thereof in pharmaceuticals
11/26/2013	US8592560 Antibodies to apical intestinal receptors and methods of treating metabolic disease
11/26/2013	US8592558 H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
11/26/2013	US8592551 Biomolecular recognition of crystal defects
11/26/2013	US8592368 JAK/STAT inhibitors and MAPK/ERK inhibitors for RSV infection

1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 1823